跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVEROLIMUS BIOCON TABLETS 0.75mg - HSA Drug Approval Details
Approvals
/
HSA
/
EVEROLIMUS BIOCON TABLETS 0.75mg
Approved
THERAPEUTIC
EVEROLIMUS BIOCON TABLETS 0.75mg
Biocon Limited (Site-2) (INDIA)BIOCON PHARMA LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 14, 2026
Approval ID
4711923143ba07e5
Company
Biocon Limited (Site-2) (INDIA)BIOCON PHARMA LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
4711923143ba07e5
Drug Name
EVEROLIMUS BIOCON TABLETS 0.75mg
Product Name
EVEROLIMUS BIOCON TABLETS 0.75mg
Approval Number
SIN17584P
Approval Date
2026-07-14
Registrant
TAEVAS LIFE SCIENCES PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 14, 2026
Approval ID
4711923143ba07e5
Type
Therapeutic
Back to HSA Approvals